Skip to content
Loading…
Kimberly-Clark Corp. is selling investment-grade bonds in as many as five parts to help fund its pending acquisition of Tylenol maker Kenvue Inc.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.